
We've moved! We no longer use this account. Please follow us at @Bioprocess365 to stay part of the conversation
UK
Joined July 2008
- Tweets1.2K
- Following2K
- Followers1.4K
- Likes62
We've moved! We no longer use this account - follow us at @Bioprocess365 for the latest news, content & events
2
What are the need-to-know #regulatory, #nonclinical & #clinical-specific characteristics of #microbiome products? Find out in a pre-conference workshop 'navigating the regulatory landscape for microbiome #therapeutics' with @VCLSsocial (27 March, Vienna): https://xitter.cf/t.co/8i2ieefEnZ
2
Have you heard? We’re going through some changes. Our new account would love to meet you. Find us at @Bioprocess365
We’re moving! As of 10 June we’ll no longer be using this account. Follow @Bioprocess365 to keep getting updates
Dr. Victor Vinci, CSO @CookMedical told us why CMOs have a key role in the future of the #bioprocessing industry spr.ly/6016BUd14
Do CMOs act as a microcosm of the enormous change, excitement & complications in the wider #bioprocessing industry? spr.ly/6010BUd1e
"Traditional #pharma timelines need to be shorter & CMOs should have a part to play in that” spr.ly/6019BUd1W
WATCH: We spoke to Dr. Victor Vinci, CSO @CookMedical, about current CMO trends spr.ly/6019BUd1J
WATCH: We spoke to Dr. Victor Vinci, CSO @CookMedical, about the trends, risks and tech in the CMO industry spr.ly/6017BUdEW
2
The global cancer #immunotherapies market is expected to grow by over 15% each year until 2020 prnewswire.com/news-releases…
Are there a raft of multi-billion dollar #biotech deals in the pipeline? fiercebiotech.com/big-biopha…
“There are two main issues in the #bioproduction industry if you look at it from a 30,000 foot view" spr.ly/6012BW4EM
Biopharma companies dominate @bcgperspectives's list of the world’s top value creators, @regeneron taking top spot spr.ly/6013BWZAd
How has the FDA amended regulations on general biologic standards for first time since 1977? spr.ly/6016BWZAM via @RAPSorg
6 reasons why the #biosimilars market is exp. to grow from $1.7b to $30b by 2020. @Frost_Sullivan for @BioProcessOL spr.ly/6018BWZAE
Homology Medicines raises $43m funding with claim of "next generation #gene editing technology" spr.ly/6016BWZU4
Following approval in Japan for their insulin biosimilar, the future is looking bright for @Bioconlimited spr.ly/6018Bi7Sj
.@GSK claim #gene therapy Strimvelis will be "significantly less" than $1m per patient spr.ly/6014BiaB8 via @FiercePharma
We've Moved retweeted
David Radspinner, General Manager of @GEHealthcare Cell Culture, told us how they are improving production informabiopharm.wordpress.co…
New @IMSHealth report claims #biosimilars could save US & Europe $110billion by 2020. Read the full report here spr.ly/6017B9vex
2






